Raptor Pharmaceutical Corp Stock
Equities
US75382F1066
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
Kim Lee
IRC | Investor Relations Contact | - | 14-10-22 |
Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 14-12-31 |
Timothy Walbert
BRD | Director/Board Member | 57 | 11-04-10 |
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.46% | 22.2B | |
-16.53% | 21.23B | |
-8.96% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- Stock